357 related articles for article (PubMed ID: 15299064)
1. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
2. In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF.
Blankenberg FG; Backer MV; Levashova Z; Patel V; Backer JM
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):841-8. PubMed ID: 16699765
[TBL] [Abstract][Full Text] [Related]
3. Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF.
Levashova Z; Backer M; Backer JM; Blankenberg FG
J Nucl Med; 2009 Dec; 50(12):2058-63. PubMed ID: 19910439
[TBL] [Abstract][Full Text] [Related]
4. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
5. Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties.
Wållberg H; Orlova A; Altai M; Hosseinimehr SJ; Widström C; Malmberg J; Ståhl S; Tolmachev V
J Nucl Med; 2011 Mar; 52(3):461-9. PubMed ID: 21321280
[TBL] [Abstract][Full Text] [Related]
6. Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m.
Levashova Z; Backer M; Backer JM; Blankenberg FG
Bioconjug Chem; 2008 May; 19(5):1049-54. PubMed ID: 18407683
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
8. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.
Camacho X; García MF; Calzada V; Fernández M; Porcal W; Alonso O; Gambini JP; Cabral P
Curr Radiopharm; 2013 Mar; 6(1):12-9. PubMed ID: 23035645
[TBL] [Abstract][Full Text] [Related]
10. A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
Chan C; Sandhu J; Guha A; Scollard DA; Wang J; Chen P; Bai K; Lee L; Reilly RM
J Nucl Med; 2005 Oct; 46(10):1745-52. PubMed ID: 16204726
[TBL] [Abstract][Full Text] [Related]
11. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
[TBL] [Abstract][Full Text] [Related]
12. [(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.
Camacho X; García MF; Calzada V; Fernández M; Chabalgoity JA; Moreno M; Barbosa de Aguiar R; Alonso O; Gambini JP; Chammas R; Cabral P
Oncology; 2013; 84(4):200-9. PubMed ID: 23328435
[TBL] [Abstract][Full Text] [Related]
13. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin.
Dupuis J; Harel F; Fu Y; Nguyen QT; Letourneau M; Préfontaine A; Fournier A
J Nucl Med; 2009 Jul; 50(7):1110-5. PubMed ID: 19525474
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
17. Labeling of epirubicin with technetium-99m: Optimization, biodistribution and scintigraphic imaging in tumor bearing mice.
Hina S; Bokhari TH; Roohi S; Rajoka MI; Sohaib M
Pak J Pharm Sci; 2018 Mar; 31(2):517-524. PubMed ID: 29618443
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
King R; Surfraz MB; Finucane C; Biagini SC; Blower PJ; Mather SJ
J Nucl Med; 2009 Apr; 50(4):591-8. PubMed ID: 19289435
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
20. Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.
Kumar S; Kumar Mishra A; Chhikara BS; Chuttani K; Kumar Sharma R
Hell J Nucl Med; 2008; 11(2):91-5. PubMed ID: 18815662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
